abstract |
The present invention relates to N1- [2,2-dimethyl-1S- (pyridin-2-ylcarbamoyl) -propyl] -N4-hydroxy-2R-isobutyl-3S-methoxy-succinamide, a matrix metalloproteinase inhibitor. The present invention also provides a pharmaceutical composition comprising the compound, which is useful in the treatment of, inter alia, rheumatoid arthritis, cancer, multiple sclerosis or psoriasis. SHE |